What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
Jay N. Cohn mostly deals with Internal medicine, Heart failure, Cardiology, Ejection fraction and Placebo.
His Internal medicine research focuses on Endocrinology and how it relates to Quartile.
His Heart failure research incorporates elements of Anesthesia, Plasma renin activity, Valsartan, Heart disease and Enalapril.
The concepts of his Cardiology study are interwoven with issues in Surgery, Blood pressure and Norepinephrine.
His Ejection fraction research incorporates themes from Beta blocker, Diastole, Veterans Affairs and Confidence interval.
His research integrates issues of Carvedilol, Clinical trial, Mortality rate, Adverse effect and Digoxin in his study of Placebo.
His most cited work include:
- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. (6679 citations)
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure (3822 citations)
- Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. (3101 citations)
What are the main themes of his work throughout his whole career to date?
Jay N. Cohn focuses on Internal medicine, Cardiology, Heart failure, Blood pressure and Hemodynamics.
His research on Internal medicine frequently links to adjacent areas such as Endocrinology.
Within one scientific family, Jay N. Cohn focuses on topics pertaining to Placebo under Cardiology, and may sometimes address concerns connected to Randomized controlled trial.
Jay N. Cohn specializes in Heart failure, namely Ejection fraction.
Many of his studies involve connections with topics such as Compliance and Blood pressure.
His Hemodynamics study frequently draws connections to other fields, such as Mean arterial pressure.
He most often published in these fields:
- Internal medicine (77.59%)
- Cardiology (66.28%)
- Heart failure (54.76%)
What were the highlights of his more recent work (between 2004-2021)?
- Internal medicine (77.59%)
- Cardiology (66.28%)
- Heart failure (54.76%)
In recent papers he was focusing on the following fields of study:
Jay N. Cohn mainly focuses on Internal medicine, Cardiology, Heart failure, Blood pressure and Intensive care medicine.
His study in Endocrinology extends to Internal medicine with its themes.
In his study, which falls under the umbrella issue of Cardiology, Pharmacology is strongly linked to Placebo.
His Heart failure research is mostly focused on the topic Ejection fraction.
His Intensive care medicine study combines topics in areas such as Psychological intervention, Health care and Myocardial infarction.
His Valsartan research incorporates themes from Randomized controlled trial and Renal function.
Between 2004 and 2021, his most popular works were:
- Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure (596 citations)
- From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report (570 citations)
- C-Reactive Protein in Heart Failure Prognostic Value and the Effect of Valsartan (349 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Blood pressure
Jay N. Cohn spends much of his time researching Internal medicine, Cardiology, Heart failure, Valsartan and Blood pressure.
The concepts of his Internal medicine study are interwoven with issues in Surgery and Intensive care medicine.
His research in Cardiology intersects with topics in Placebo and Arterial stiffness.
He is studying Ejection fraction, which is a component of Heart failure.
His work deals with themes such as Brain natriuretic peptide, Clinical trial, New York Heart Association Class, Renal function and Confidence interval, which intersect with Valsartan.
Jay N. Cohn combines subjects such as Hemodynamics, Anesthesia, Asymptomatic and Endothelial dysfunction with his study of Blood pressure.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
